Zivo Bioscience Inc (ZIVO)

US · Healthcare · Biotechnology

$3.52-14.27%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Net profit

$-512,484

EPS

$-0.27

EPS estimate

$-0.36

EPS came in at -0.27 against a street estimate of -0.36 — a beat of 25.0%.

Market cap

$17.3M

Forward P/E

0.0

P/B

21.13

Book value

$-0.86

EPS (TTM)

$-2.18

52-week high

$17.50

52-week low

$1.11

50-day MA

$4.23

200-day MA

$6.13

Beta

0.18

Analysts rate Zivo Bioscience Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $12.00.

Insiders

47.30%

Institutions

0.10%

Fund	Stake
CoreCap Advisors, LLC	0.10%
Huntington National Bank	0.00%
Kohmann Bosshard Financial Services, LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Zivo Bioscience Inc — free to start.

Data updated 2026-09-18.